InvestSMART

Singular Health Group Ltd (ASX:SHG)

ALERT: Price-sensitive ASX Announcement for SHG
Current share price for SHG : $0.185 -0.015 (-7.50%)+
Announcement
Release
31 Jul 2026 11:42AM
Price at Release
$0.200
Full Release
download
Summary
Singular Health Group Ltd's quarterly report for the period ending 30 June 2026 highlights its financial activities and strategic advancements. The company maintained its robust cash position with $10.069 million at the end of the quarter and a funding runway of nearly two years. During this period, Singular Health focused on expanding its 3DICOM™ platform in the U.S., including pilot projects with PNS and a Memorandum of Understanding with Stellae Health. The company also worked on maintaining compliance certifications and advancing its intellectual property portfolio. Key financial activities included receiving a $795,000 option exercise, disposing of non-core assets for $127,000, and planning further commercial expansions in the healthcare and educational sectors.
Key Points
  • Strong cash position of $10.069 million at quarter-end
  • Pilot deployment of 3DICOM™ platform with Stellae Health
  • Expansion of 3DICOM™ platform in the U.S.
  • Receipt of $795,000 from option exercise
  • Disposal of non-core assets for $127,000
  • Maintenance of compliance certifications
  • Advancement in intellectual property portfolio
  • Funding runway of nearly two years
  • Focus on U.S. commercial expansion and healthcare opportunities
  • Memorandum of Understanding with Stellae Health
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.